Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists.
Patberg M, Isaak A, Füsser F, Ortiz Zacarías NV, Vinnenberg L, Schulte J, Michetti L, Grey L, van der Horst C, Hundehege P, Koch O, Heitman LH, Budde T, Junker A. Patberg M, et al. Among authors: isaak a. Eur J Med Chem. 2021 Dec 15;226:113838. doi: 10.1016/j.ejmech.2021.113838. Epub 2021 Sep 16. Eur J Med Chem. 2021. PMID: 34571173
Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease.
Turgutalp B, Bhattarai P, Ercetin T, Luise C, Reis R, Gurdal EE, Isaak A, Biriken D, Dinter E, Sipahi H, Schepmann D, Junker A, Wünsch B, Sippl W, Gulcan HO, Kizil C, Yarim M. Turgutalp B, et al. Among authors: isaak a. J Med Chem. 2022 Sep 22;65(18):12292-12318. doi: 10.1021/acs.jmedchem.2c01003. Epub 2022 Sep 9. J Med Chem. 2022. PMID: 36084304
Correction to "Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease".
Turgutalp B, Bhattarai P, Ercetin T, Luise C, Reis R, Gurdal EE, Isaak A, Biriken D, Dinter E, Sipahi H, Schepmann D, Junker A, Wünsch B, Sippl W, Gulcan HO, Kizil C, Yarim M. Turgutalp B, et al. Among authors: isaak a. J Med Chem. 2023 Jan 26;66(2):1652. doi: 10.1021/acs.jmedchem.2c02094. Epub 2023 Jan 18. J Med Chem. 2023. PMID: 36651752 No abstract available.
Generative Pre-trained Transformer 4 makes cardiovascular magnetic resonance reports easy to understand.
Salam B, Kravchenko D, Nowak S, Sprinkart AM, Weinhold L, Odenthal A, Mesropyan N, Bischoff LM, Attenberger U, Kuetting DL, Luetkens JA, Isaak A. Salam B, et al. Among authors: isaak a. J Cardiovasc Magn Reson. 2024 Mar 7;26(1):101035. doi: 10.1016/j.jocmr.2024.101035. Online ahead of print. J Cardiovasc Magn Reson. 2024. PMID: 38460841 Free PMC article.
Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization.
Wagenpfeil J, Kupczyk PA, Bruners P, Siepmann R, Guendel E, Luetkens JA, Isaak A, Meyer C, Kuetting F, Pieper CC, Attenberger UI, Kuetting D. Wagenpfeil J, et al. Among authors: isaak a. Front Radiol. 2024 Feb 20;4:1346550. doi: 10.3389/fradi.2024.1346550. eCollection 2024. Front Radiol. 2024. PMID: 38445105 Free PMC article.
122 results